Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and emerging long-acting antipsychotics for the treatment of schizophrenia
Renato de Filippis, Pasquale De Fazio, Raffaele Gaetano, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 7, pp. 771-790
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Lipid based intramuscular long-acting injectables: Current state of the art
Janine M. Wilkinson, Damilola Ajulo, Valeria Tamburrini, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 178, pp. 106253-106253
Open Access | Times Cited: 36
Postoperative psychological factors and quality of life but not shoulder brace adherence affect clinical outcomes after arthroscopic rotator cuff repair
Michele Mercurio, Davide Castioni, Renato de Filippis, et al.
Journal of Shoulder and Elbow Surgery (2023) Vol. 32, Iss. 9, pp. 1953-1959
Open Access | Times Cited: 18
Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults
Ludovic Samalin, Ludivine Boudieu, Pierre‐Michel Llorca
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 3, pp. 291-298
Closed Access | Times Cited: 4
Continuous Microfluidic Antisolvent Crystallization as a Bottom-Up Solution for the Development of Long-Acting Injectable Formulations
Snehashis Nandi, Laura Verstrepen, Mariana Hugo Silva, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 376-376
Open Access | Times Cited: 4
Editorial: Safety and side effects of psychotropic medications, volume III
Renato de Filippis, Mireia Solerdelcoll, Mohammadreza Shalbafan
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Transitions in Mental Health Care Utilization at GHU Paris Between 2019 and 2024: A Post-Pandemic Perspective
Anne Perozziello, Alexandre Sta, Béatrice Aubriot, et al.
Psychiatry Research (2025), pp. 116482-116482
Open Access
Editorial: Safety and side effects of psychotropic medications
Renato de Filippis, Mireia Solerdelcoll, Mohammadreza Shalbafan
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 9
Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study
Renato de Filippis, Filippo Antonio Staltari, Matteo Aloi, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 577-577
Open Access | Times Cited: 9
Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database
Giuseppe Cicala, Renato de Filippis, María Antonietta Barbieri, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 9
Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia
Lindsey Peters, Megan Dyer, Emily B. Schroeder, et al.
Journal of Pharmacy Technology (2023) Vol. 39, Iss. 2, pp. 88-94
Closed Access | Times Cited: 8
Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis
Renato de Filippis, Michele Mercurio, Giovanna Spina, et al.
Healthcare (2022) Vol. 10, Iss. 5, pp. 803-803
Open Access | Times Cited: 14
Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia
Renato de Filippis, Matteo Aloi, Marco Tullio Liuzza, et al.
Comprehensive Psychiatry (2024) Vol. 133, pp. 152496-152496
Open Access | Times Cited: 2
Applying a clinical staging model in patients affected by schizophrenia spectrum disorder
Renato de Filippis, Elvira Anna Carbone, Marianna Rania, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Latent profile analysis identifies four different clinical schizophrenia profiles through aberrant salience
Matteo Aloi, Renato de Filippis, Elvira Anna Carbone, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Achieving long-term goals through early personalized management of schizophrenia: expert opinion on the role of a new fast-onset long-acting injectable antipsychotic
Antonio Vita, Andrea Fagiolini, Giuseppe Maina, et al.
Annals of General Psychiatry (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Micronization of naringenin in supercritical fluid medium: In vitro and in vivo assays
Patrícia Viera de Oliveira, Otávio Sanaiotto, Ketelin Z. Kuhn, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104382-104382
Closed Access | Times Cited: 6
Psychometric Properties of the 9-Item Shared Decision-Making Questionnaire (SDM-Q-9): Validation of the Italian Version in a Large Psychiatric Clinical Sample.
Renato de Filippis, Matteo Aloi, Anna Maria Pilieci, et al.
PubMed (2022) Vol. 19, Iss. 4, pp. 264-271
Closed Access | Times Cited: 9
What is the significance of the impact of antipsychotics on the gut microbiome?
Mary V. Seeman
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 3, pp. 125-127
Closed Access | Times Cited: 5
Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia
Chao Cai, Chris M Kozma, Charmi Patel, et al.
Journal of Managed Care & Specialty Pharmacy (2024) Vol. 30, Iss. 6, pp. 549-559
Open Access | Times Cited: 1
Assessing the impact of long‐acting injectable compared to oral antipsychotic medications on readmission to a state psychiatric hospital
Chizimuzo T.C. Okoli, Bassema Abufarsakh, Tianyi Wang, et al.
Journal of Psychiatric and Mental Health Nursing (2024) Vol. 31, Iss. 6, pp. 1155-1163
Closed Access | Times Cited: 1
Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
Renato de Filippis, Raffaele Gaetano, Georgios Schoretsanitis, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2141-2150
Open Access | Times Cited: 7
Long-acting Injectable Antipsychotics and Stigma: Some Considerations and Future Perspectives
Antimo Natale, Laura Fusar‐Poli, Andrea Amerio, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 13, pp. 981-983
Closed Access | Times Cited: 2
The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study
Andrea Aguglia, Laura Fusar‐Poli, Andrea Amerio, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 5
TRATAMENTO FARMACOLÓGICO DA ESQUIZOFRENIA: UMA REVISÃO DAS ESTRATÉGIAS ATUAIS
Silvio Vieira da Silva, Ana Clara Santos de Oliveira, Melissa Magalhães Silva Gualberto, et al.
Revista Ibero-Americana de Humanidades, Ciências e Educação (2024) Vol. 10, Iss. 6, pp. 1130-1138
Open Access
Introduction to Complex Brain Disorders, Currently Available Therapies, and Their Limitations
Suraj Kendre, Mayur Kumbhare, Awanish Mishra
(2024), pp. 1-14
Closed Access
Page 1 - Next Page

Scroll to top